Abhijit Trailokya

Doctor - Cited by 183

Biography

Dr Abhijit Trailokya Presently holding a position of deputy GM- Medical affairs. Was chief Medical Advisor for Abbott (Mumbai). Completed MBBS from Mumbai, Master’s In Pharmaceutical Medicine, Diploma in Business Management (DBM) and MBA from Welingkar Institute, Mumbai.Completed Post Graduate Diploma in Hospital Management (PGDHM&A) from AIIMS and Post Graduate Diploma in Clinical Research from Academy for Clinical Excellence (ACE).

Title

Cited by

Year

Calcium and calcium salts

A Trailokya, A Srivastava, M Bhole, N ZalteJournal of the Association of Physicians of India 65 (1), 1-2, 2017201

2017

Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.

A Trailokya, JS Hiremath, JPS Sawhney, YK Mishra, V Kanhere, ...The Journal of the Association of Physicians of India 64 (2), 88-93, 2016201

2016

A Study of salt and fat consumption pattern in regional Indian diet among hypertensive and dyslipidemic patients-SCRIPT study

D Kumbla, M Dharmalingam, K Dalvi, S Ray, MK Shah, S Gupta, ...J Assoc Physicians India 64 (12), 47-54, 2016201

2016

Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week …

AK Ajmani, A Agrawal, BLN Prasad, I Basu, J Shembalkar, N Manikanth, ...Diabetes Research and Clinical Practice 157, 107860, 2019201

2019

Acenocoumarol in thromboembolic disorders

A TrailokyaCardiovasc. Pharmacol. Open Access 4, 2015201

2015

WIN OVER study: Efficacy and safety of olmesartan in Indian hypertensive patients: Results of an open label, non-comparative, multi-centric, post marketing observational study

DK Kumbla, S Kumar, YV Reddy, A Trailokya, M Naikindian heart journal 66 (3), 340-344, 2014201

2014

Fondaparinux in acute coronary syndromes

A Trailokya, A Dhall, DK KumblaJournal of the Association of Physicians of India 63 (7), 83-87, 20120

2015

Will Azilsartan-An eight ARB bring paradigm shift in hypertension management practices in India

A TrailokyaCardiovasc Pharm Open Access , 189, 2016201

2016

Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study).

RK Singh, A Trailokya, MM NaikThe Journal of the Association of Physicians of India 63 (), 30, 32-5, 2015201

2015

DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).

N Malhotra, MK Keshan, A Agarwal, RA Kumar, A Trailokya, K Dalvi, ...The Journal of the Association of Physicians of India 6 (), 38-6, 2016201

2016

Current Role of Dapagliflozin in Clinical Practice.

AH Zargar, AA Trailokya, S Ghag, R Pawar, A Aiwale, A ZalkeThe Journal of the Association of Physicians of India 69 (9), 11-12, 2021202

2021

Overview of reteplase, A novel thrombolytic agent in Indian context

A Dasbiswas, J Hiremath, A TrailokyaCardiol Pharmacol 4, 16-142, 2015201

2015

Dabigatran-the First Approved DTI for SPAF.

A Trailokya, JS HiremathThe Journal of the Association of Physicians of India 66 (4), 85-90, 2018201

2018

Practice of Indian physicians towards use of calcium channel blockers in the management of hypertension: a paper based questionnaire survey

K Dalvi, A Trailokya, K PatelInd Med Gaz, 34-9, 01501

2015

Clinical Evidence of Evogliptin plus Metformin in Management of Type 2 Diabetes mellitus.

Clinical Evidence of Evogliptin plus Metformin in Management of Type Diabetes mellitus.S Bajaj, A Aiwale, A Trailokya, A SharmaThe Journal of the Association of Physicians of India 69 (), 5-9, 010

2021

Acenocoumarol in the geriatric population

A Trailokya, A BahulayanJ Clin Exp Cardiology 7, -2, 20620

2016

Role of Patient Education and Counseling in Acenocoumarol Management

A TrailokyaInternMed 6 (22), 2, 20620

2016

Management practices in hypertension: results of WIN-OVER-A Pan India Registry

A Trailokya, K Patel, K DalviIndian Medical Gazette 49, 62-67, 20520

2015

Arbekacin-A Novel Antibiotic for Critical Infections.

G Panchal, R Pandit, A Trailokya, A SharmaThe Journal of the Association of Physicians of India 67 (7), 93-97, 20920